<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ImClone Systems Inc. | Company News & Executive Profiles - IMCL | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/imclone+systems+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for ImClone Systems Inc.]]></description>
	<s:counts start="0" returned="10" found="442" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Pension Fund Thinks Lilly / Imclone Deal Too Cheap]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F103195-pension-fund-thinks-lilly-imclone-deal-too-cheap%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  I honestly didn&#8217;t think I&#8217;d ever get the chance to write about Imclone IMCL again. But never say never! It turns out that a pension fund, the State Retirement System of Massachusetts, is suing to block the Lilly LLY acquisition &#8211; because, hold on to your...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 31 Oct 2008 01:18:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pension+fund.html"><![CDATA[Pension Fund]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/payroll+solutions.html"><![CDATA[Payroll Solutions]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">LLY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Is Eli Lilly ImClone's Secret Bidder?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F98359-is-eli-lilly-imclone-s-secret-bidder%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  The Wall Street Journal unmasked the identity--Eli Lilly LLY--of ImClone's IMCL secret suitor. A spokesman for LLY said he couldn't confirm or deny the report. IMCL put out a press release Wednesday night saying that the mystery bidder has asked to remain anonymous. by Mike Huckman]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 02 Oct 2008 11:57:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">LLY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Eli Lilly, ImClone: The Waiting Game Continues]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F97870-eli-lilly-imclone-the-waiting-game-continues%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Eli Lilly LLY has been running direct-to-doctor ads over the past few months telling physicians that Effient, the company's new bloodthinner, is "Coming Soon." Well, it may have jumped the gun.  The Food and Drug Administration, which had put Effient on a fast-track toward potential...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 29 Sep 2008 12:56:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">LLY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Predictions on Imclone's Suitors]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F97693-predictions-on-imclone-s-suitors%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  So it seems that Bristol-Myers Squibb BMY took my advice (yeah, sure) and made an insultingly incremental counteroffer for Imclone IMCL , raising their $60/share all the way to. . .$62. I was hoping for something more like $60.25 myself, but you can&#8217;t have everything (I...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 28 Sep 2008 08:50:37 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[BMY Ups the Ante on ImClone]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F96881-bmy-ups-the-ante-on-imclone%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Last night, Bristol-Myers BMY announced plans to increase its bid for the remaining 83% of ImClone Systems IMCL that it does not already own, to $62 per share, and plans to take the offer directly to shareholders in the form of a tender offer. ImClone and Chairman...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 23 Sep 2008 03:34:56 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Raises ImClone Offer to $62]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F96866-bristol-myers-raises-imclone-offer-to-62%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ron Haruni submits: In a letter send Monday to Carl Ichan, the Chairman of ImClone Systems IMCL, Bristol-Myers Squibb BMY, announced that after consulting with external financial advisors, the company has concluded that its initial $60 per share all cash offer made two months ago for ImClone was inadequate. Therefore,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 23 Sep 2008 02:55:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_22/ai_n28575640]]></link>
		<description><![CDATA[NEW YORK -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it is increasing its initial offer for ImClone Systems Incorporated (NASDAQ: IMCL) and intends to commence a tender offer for the currently outstanding shares of common stock of ImClone that are not already owned by Bristol-Myers Squibb for $62.00...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 22 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Meyers Squibb vs. Imclone: Icahn Stirs Up the Pot]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F95330-bristol-meyers-squibb-vs-imclone-icahn-stirs-up-the-pot%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  I haven&#8217;t mentioned the attempt by Bristol-Meyers Squibb BMY to buy out Imclone IMCL until now. The reasons for the move are unsurprising &#8211; BMS would like all the revenue from Erbitux, instead of just a share of it, and sees some value coming up in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 14 Sep 2008 03:00:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Status Report: ImClone Systems - Bristol-Myers Squibb]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F95286-status-report-imclone-systems-bristol-myers-squibb%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The M & A Researcher submits:  On Thursday, September 11, Bristol-Myers Squibb BMY  issued this letter to ImClone Systems IMCL in response to IMCL's offer rejection. Excerpts include the following:  As you know, Bristol-Myers holds the exclusive, long-term marketing rights in the United States to ERBITUX® and related...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sat, 13 Sep 2008 11:45:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
	<item>
		<title><![CDATA[Ownership of Erbitux Follow-On Is Central to ImClone Takeover]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F95269-ownership-of-erbitux-follow-on-is-central-to-imclone-takeover%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: The escalating squabble between Bristol-Myers Squibb BMY and  ImClone Systems IMCL over ownership of the potentially valuable  Erbitux follow-on,  IMC-11F8, is likely to be a big factor in determining whether a third party makes a firm offer for the US biotech. A look at...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sat, 13 Sep 2008 11:31:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/imclone+systems+inc..html"><![CDATA[ImClone Systems Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMCL</category>
		<category domain="tickers">BMY,IMCL</category>
	</item>
</channel>
</rss>
